Abiopharma

🔍 Mitra Shankh (Executive)

Company: WELLTOWER INC. (WELL)

Report Date: 2026-05-31

Detailed Transactions and Holdings:

• Acquired 17 shares of Common Stock at $173.32 per share (Direct)
  Date: 2026-05-31 | Code: A | equity_swap_involved: false | shares_owned_after: 76,494.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 3,852 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: G | equity_swap_involved: false | shares_owned_after: 72,642.00 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-31 | Code: H | nature_of_ownership: By Children | shares_owned_after: 62.00 | Footnotes: F3

Footnotes:

• F1: The reporting person is voluntarily reporting the acquisition of common shares, par value $1.00 per share ("Common Shares"), of Welltower Inc. (the "Issuer") pursuant to the Welltower Inc. Employee Stock Purchase Plan ("ESPP"). This transaction was exempt under both Rule 16b-3(c) and Rule 16b-3(d).
• F2: In accordance with the ESPP these Common Shares were purchased at a price equal to 85% of the closing price of Common Shares on December 1, 2025, the first trading day of the offering period.
• F3: The reporting person disclaims beneficial ownership of the Common Shares owned by children who share the reporting person's household. This report should not be deemed an admission that the reporting person is the beneficial owner of such Common Shares for purposes of Section 16 for any other purpose.